Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,738
datasets available to search
ShareScore release 0.9.0
Dataset results
2,738 results for “Multiple sclerosis”
Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications
ClinicalTrials.gov study NCT01834586. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis
ClinicalTrials.gov study NCT04480307. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effectiveness of Rebif® in Clinically Isolated Syndrome and Relapsing Multiple Sclerosis Using RebiSmart™
ClinicalTrials.gov study NCT02254304. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of a Modified Paleolithic Dietary Intervention in the Treatment of Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT02687919. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT02045732. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)
ClinicalTrials.gov study NCT04997148. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pilot Project for Multifidus Muscle Evaluation in Patients With Multiple Sclerosis
ClinicalTrials.gov study NCT05427045. IPD Sharing: NO. Countries: 1. Publications: 0.
Tolebrutinib, a Brain-penetrant Bruton's Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
ClinicalTrials.gov study NCT04742400. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia
ClinicalTrials.gov study NCT03110315. IPD Sharing: NO. Countries: 1. Publications: 0.
Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)
ClinicalTrials.gov study NCT03126760. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy Study of Oral Fampridine-SR in Patients With Multiple Sclerosis
ClinicalTrials.gov study NCT00053417. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Prospective Study of Spasticity in Individuals With Multiple Sclerosis
ClinicalTrials.gov study NCT01111435. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natalizumab as an Efficacy Switch in Participants With Relapsing Multiple Sclerosis After Failure on Other Therapies
ClinicalTrials.gov study NCT02241785. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis
ClinicalTrials.gov study NCT03046251. IPD Sharing: NO. Countries: 1. Publications: 0.
Assessing the Effects of Ongoing Ocrelizumab (OCR) Therapy on Fatigue and Cognition in Veterans With Multiple Sclerosis
ClinicalTrials.gov study NCT07181811. IPD Sharing: NO. Countries: 1. Publications: 0.
Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017)
ClinicalTrials.gov study NCT01939002. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis
ClinicalTrials.gov study NCT06430671. IPD Sharing: NO. Countries: 4. Publications: 0.
Patient Experiences of Multiple Sclerosis (PExMS)
ClinicalTrials.gov study NCT04236544. IPD Sharing: YES. Countries: 0. Publications: 31.
Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (P
ClinicalTrials.gov study NCT06675864. IPD Sharing: YES. Countries: 7. Publications: 0.
Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT02090413. IPD Sharing: Not stated. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.